Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cipta Sarana Medika Tbk. (DKHH) vs Penta Valent Tbk. (PEVE) Price & Performance

Cipta Sarana Medika Tbk.Trade
Penta Valent Tbk.Trade

Price performance (Past 24H)

Key statistics

Cipta Sarana Medika Tbk. vs Penta Valent Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp64 (market cap 160.67B, 24.02M 24h volume), while Penta Valent Tbk. trades at Rp310 (market cap 547.34B, 520.2K 24h volume). The key difference: Penta Valent Tbk. is far larger — about 3.4× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (24.02M versus 520.2K). Which is the better fit depends on your goals.

DKHHPEVE
Market Cap
160.67B547.34B
Volume
24.02M520.2K
Lot
240.19K5.2K
Turnover
1.56B161.08M
Average Price
65309.65
Value
1.56B161.08M
Indicative Equilibrium Price
64
Indicative Equilibrium Volume
1.67K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DKHH
View details
PEVE
View details

About Cipta Sarana Medika Tbk.

PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.

Read more on DKHH

About Penta Valent Tbk.

PT Penta Valent Tbk (the Company) was established in 1968 in Jakarta, Indonesia under the name of CV Penta Valent, hereinafter, based on Notarial Deed No. 48 of Bebasa Daeng Lalo, S.H., dated August 16, 1972. The Company started its commercial operations in 1968. PT Tancorp Global Sentosa, a company incorporated in Indonesia, is the ultimate parent entity of the Company.

Read more on PEVE